Advanced search
Publication Cover
mAbs Volume 13, 2021 - Issue 1
Submit an article Journal homepage
2,776
Views
5
CrossRef citations to date
0
Altmetric
Reports

Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model

Parul Guptaa Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USA;b Biomedicine Design, Pfizer Inc., San Diego, CA, USAView further author information
,
Ziyue Karen Jianga Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information
,
Bing Yanga Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information
,
Lisa Manzuka Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information
,
Edward Rosfjordc Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information
,
Johnny Yaoc Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information
,
Luanna Lemonc Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information
,
Kavon Noorbeheshta Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information
,
John Davida Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information
,
Sujiet Puthenveetild Medicinal Sciences, Pfizer Incorporated, San Diego, CA, USAView further author information
,
Jeffrey M. Casavantd Medicinal Sciences, Pfizer Incorporated, San Diego, CA, USAView further author information
,
Elwira Muszynskac Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information
,
Fengping Lib Biomedicine Design, Pfizer Inc., San Diego, CA, USAView further author information
,
Mauricio Lealb Biomedicine Design, Pfizer Inc., San Diego, CA, USAView further author information
,
Puja Saprac Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information
&
Anand Giddabasappaa Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1546-2481View further author information
ORCID Icon show all
Article: 1958662 | Received 22 Jan 2021, Accepted 19 Jul 2021, Published online: 04 Aug 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.